US · Healthcare

StageZero Life Sciences Ltd (SZLSF)

Diagnostics & Research

StageZero Life Sciences Ltd (SZLSF) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SZLSF

P/E ratio

18.00

StageZero Life Sciences Ltd (SZLSF) — FAQ

What is SZLSF's P/E ratio?

The price-to-earnings (P/E) ratio for StageZero Life Sciences Ltd (SZLSF) is 18.00 (data as of 2026-05-23).

Does StageZero Life Sciences Ltd pay a dividend?

Dividend yield is not available in the current snapshot for StageZero Life Sciences Ltd (SZLSF). Check the MyAverix Finance app for the latest dividend data.

What sector is StageZero Life Sciences Ltd in?

StageZero Life Sciences Ltd (SZLSF) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is SZLSF listed on?

SZLSF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)